肺癌靶向治疗耐药机理和免疫治疗的预测研究

Study on the mechanism of drug resistance in targeted therapy of lung cancer and the prediction of immunotherapy

医促会胸部肿瘤分会委员🤸；中华医学会结核相关疾病专业委员会常务委员;

中国肿瘤医师协会青委会委员🏯；中国临床肿瘤学会血管靶向治疗专家委员会委员👩🏿‍🍼；

Member of Thoracic Oncology Branch of Medical Promotion Association; Member of the standing Committee of the Professional Committee of Tuberculosis related Diseases of Chinese Medical Association; Member of the Youth Committee of the Chinese Association of Oncologists; Member of the expert Committee on Vascular targeted Therapy of the Chinese Society of Clinical Oncology.

作为第一作者或者通讯作者已经发表SCI收录论文20余篇， 其中单篇文章的最高影响因子为18分； 作为课题负责人获得国家自然科学基金（面上项目）资助一项👨🏻‍🎓、上海市自然科学基金（面上项目）资助3项 ;作为主要研究者发起2项IIT临床研究🎯🙇🏽。

As the first author or correspondent author, I have published more than 20 papers collected by SCI, of which the highest impact factor of a single article is 18 points. As the project leader, I have been awarded one project supported by the National Natural Science Foundation of China, 3 supported by Shanghai Natural Science Foundation, and initiated 2 IIT clinical studies as Principal Investigator(PI).